MetaCap

Alto Neuroscience (ANRO) vs Kardigan (KARD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Kardigan is the larger company by market cap ($1.08 billion vs $1.02 billion), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ANRO+11.57%KARD-47.55%
+67%+7%-53%
Jun 18, 20261 yearNov 20, 2026
ANRO+11.57%KARD-47.55%
+62%+4%-53%
Jun 15, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ANRO versus KARD key metrics
MetricANROKARD
Share price$25.37$11.54
Market cap$1.02B$1.08B
1-day change-4.30%-7.83%
YTD return+42.53%—
1-year return+91.47%—
EPS (TTM)$-2.32$-6.24
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-63.24M—
52-week high$37.48$27.00
52-week low$12.51$11.49
Distance from 52-week high-32.31%-57.26%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+52.42%+255.29%
Average volume614.92K625.83K
Shares outstanding40.11M93.60M
Employees68241
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Alto Neuroscience

ANRO stock →

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 68 employees

About Kardigan

KARD stock →

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 241 employees

ANRO vs KARD FAQ

Which is bigger, Alto Neuroscience or Kardigan?

Kardigan (KARD) is larger, with a market capitalization of $1.08B compared with $1.02B for Alto Neuroscience (ANRO).

Are Alto Neuroscience and Kardigan in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons